Daphne Quimi - Net Worth and Insider Trading
Daphne Quimi Net Worth
The estimated net worth of Daphne Quimi is at least $5 Million dollars as of 2024-03-29. Daphne Quimi is the CFO of Amicus Therapeutics Inc and owns about 398,532 shares of Amicus Therapeutics Inc (FOLD) stock worth over $5 Million. Details can be seen in Daphne Quimi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daphne Quimi has not made any transactions after 2023-01-18 and currently still holds the listed stock(s).
Transaction Summary of Daphne Quimi
Daphne Quimi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daphne Quimi owns 3 companies in total, including Amicus Therapeutics Inc () , Amylyx Pharmaceuticals Inc () , and Century Therapeutics Inc () .
Click here to see the complete history of Daphne Quimi’s form 4 insider trades.
Insider Ownership Summary of Daphne Quimi
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Amicus Therapeutics Inc | 2023-01-18 | Chief Financial Officer | |
Amylyx Pharmaceuticals Inc | 2022-01-06 | director | |
Century Therapeutics Inc | 2022-10-01 | director |
Daphne Quimi Latest Holdings Summary
Daphne Quimi currently owns a total of 1 stock. Daphne Quimi owns 398,532 shares of Amicus Therapeutics Inc (FOLD) as of January 18, 2023, with a value of $5 Million.
Latest Holdings of Daphne Quimi
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
FOLD | Amicus Therapeutics Inc | 2023-01-18 | 398,532 | 11.75 | 4,682,751 |
Holding Weightings of Daphne Quimi
Daphne Quimi Form 4 Trading Tracker
According to the SEC Form 4 filings, Daphne Quimi has made a total of 8 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Amicus Therapeutics Inc is the sale of 11,923 shares on January 18, 2023, which brought Daphne Quimi around $152,495.
Insider Trading History of Daphne Quimi
- 1
Daphne Quimi Trading Performance
Daphne Quimi Ownership Network
Ownership Network List of Daphne Quimi
Ownership Network Relation of Daphne Quimi
Daphne Quimi Owned Company Details
What does Amicus Therapeutics Inc do?
Who are the key executives at Amicus Therapeutics Inc?
Daphne Quimi is the Chief Financial Officer of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & Executive Chairman John F Crowley , director & President and CEO Bradley L Campbell , and Chief People Officer David Michael Clark .
Amicus Therapeutics Inc () Insider Trades Summary
Over the past 18 months, Daphne Quimi made 1 insider transaction in Amicus Therapeutics Inc () with a net sale of 11,923. Other recent insider transactions involving Amicus Therapeutics Inc () include a net sale of 667,360 shares made by John F Crowley , a net sale of 256,386 shares made by Bradley L Campbell , and a net sale of 51,919 shares made by David Michael Clark .
In summary, during the past 3 months, insiders sold 415,885 shares of Amicus Therapeutics Inc () in total and bought 0 shares, with a net sale of 415,885 shares. During the past 18 months, 1,262,082 shares of Amicus Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,262,082 shares.
Amicus Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Amicus Therapeutics Inc Insider Transactions
Daphne Quimi Mailing Address
Above is the net worth, insider trading, and ownership report for Daphne Quimi. You might contact Daphne Quimi via mailing address: C/o Amicus Therapeutics, Inc., 1 Cedar Brook Drive, Cranbury Nj 08512.